Silk Road Medical, Inc
NASDAQ:SILK
27.49 (USD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 51.242 | 48.484 | 47.27 | 44.435 | 45.298 | 40.131 | 40.07 | 37.374 | 33.173 | 28.021 | 28.265 | 24.701 | 26.456 | 22.053 | 21.133 | 20.067 | 15.094 | 18.933 | 18.634 | 17.026 | 14.928 | 12.766 | 11.47 | 9.614 | 7.767 | 5.706 |
| Cost of Revenue
| 12.736 | 11.983 | 12.468 | 12.05 | 13.004 | 12.526 | 10.979 | 9.308 | 9.012 | 8.577 | 7.233 | 6.076 | 6.598 | 5.538 | 5.217 | 5.488 | 5.336 | 5.25 | 4.721 | 4.17 | 3.697 | 3.339 | 3.667 | 2.882 | 2.391 | 1.934 |
| Gross Profit
| 38.506 | 36.501 | 34.802 | 32.385 | 32.294 | 27.605 | 29.091 | 28.066 | 24.161 | 19.444 | 21.032 | 18.625 | 19.858 | 16.515 | 15.916 | 14.579 | 9.758 | 13.683 | 13.913 | 12.856 | 11.231 | 9.427 | 7.803 | 6.732 | 5.376 | 3.772 |
| Gross Profit Ratio
| 0.751 | 0.753 | 0.736 | 0.729 | 0.713 | 0.688 | 0.726 | 0.751 | 0.728 | 0.694 | 0.744 | 0.754 | 0.751 | 0.749 | 0.753 | 0.727 | 0.646 | 0.723 | 0.747 | 0.755 | 0.752 | 0.738 | 0.68 | 0.7 | 0.692 | 0.661 |
| Reseach & Development Expenses
| 11.883 | 10.66 | 10.064 | 10.047 | 10.78 | 10.433 | 9.2 | 8.471 | 10.655 | 8.123 | 7.499 | 6.867 | 7.261 | 5.484 | 10.036 | 4.711 | 3.393 | 3.131 | 3.264 | 3.187 | 3.114 | 2.707 | 3.39 | 2.442 | 2.326 | 2.1 |
| General & Administrative Expenses
| 0 | 0 | 38.649 | 0 | 0 | 0 | 32.174 | 0 | 0 | 0 | 27.374 | 0 | 0 | 0 | 35.45 | 0 | 0 | 0 | 45.065 | 0 | 0 | 0 | 11.526 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0.461 | 0 | 0 | 0 | 0.347 | 0 | 0 | 0 | 0.221 | 0 | 0 | 0 | 0.194 | 0 | 0 | 0 | 0.362 | 0 | 0 | 0 | 0.186 | 0 | 0 | 0 |
| SG&A
| 43.818 | 40.775 | 39.11 | 36.009 | 35.83 | 34.082 | 32.521 | 28.821 | 27.7 | 27.275 | 27.595 | 25.049 | 22.549 | 21.194 | 20.872 | 19.202 | 15.758 | 19.692 | 18.156 | 17.064 | 14.135 | 13.866 | 11.712 | 8.973 | 7.816 | 6.319 |
| Other Expenses
| -0.004 | 0.048 | 0.477 | -0.002 | 0.11 | -0.144 | -0.028 | 0.004 | -0.05 | -0.116 | -0.012 | -0.003 | -0.006 | -0.003 | -0.006 | -0.015 | -0.056 | -0.003 | -0.008 | -0.001 | -5.333 | -15.712 | -7.148 | -3.233 | -1.898 | 0.215 |
| Operating Expenses
| 55.701 | 51.435 | 49.174 | 46.056 | 46.61 | 44.515 | 41.721 | 37.292 | 38.355 | 35.398 | 35.094 | 31.916 | 29.81 | 26.678 | 30.908 | 23.913 | 19.151 | 22.823 | 21.42 | 20.251 | 17.249 | 16.573 | 15.102 | 11.415 | 10.142 | 8.419 |
| Operating Income
| -17.195 | -14.934 | -14.372 | -13.671 | -14.316 | -16.91 | -12.63 | -9.226 | -14.194 | -15.954 | -14.062 | -13.291 | -9.952 | -10.163 | -14.992 | -9.334 | -9.393 | -9.14 | -7.507 | -7.395 | -6.018 | -7.146 | -7.299 | -4.683 | -4.766 | -4.647 |
| Operating Income Ratio
| -0.336 | -0.308 | -0.304 | -0.308 | -0.316 | -0.421 | -0.315 | -0.247 | -0.428 | -0.569 | -0.498 | -0.538 | -0.376 | -0.461 | -0.709 | -0.465 | -0.622 | -0.483 | -0.403 | -0.434 | -0.403 | -0.56 | -0.636 | -0.487 | -0.614 | -0.814 |
| Total Other Income Expenses Net
| 0.592 | 0.798 | 1.361 | -0.002 | 0.11 | 0.45 | 0.016 | 0.004 | -0.295 | -0.116 | -0.012 | -0.003 | -0.006 | -0.003 | -1.125 | -0.015 | -0.056 | -0.003 | -0.008 | -0.001 | -5.332 | -15.712 | -7.148 | -3.233 | -1.898 | 0.215 |
| Income Before Tax
| -16.603 | -14.136 | -13.011 | -12.788 | -13.484 | -16.46 | -12.614 | -10.319 | -15.398 | -16.679 | -14.693 | -13.885 | -10.539 | -10.694 | -16.756 | -10.315 | -10.353 | -9.941 | -8.291 | -8.007 | -11.959 | -24.158 | -15.619 | -8.953 | -7.651 | -5.408 |
| Income Before Tax Ratio
| -0.324 | -0.292 | -0.275 | -0.288 | -0.298 | -0.41 | -0.315 | -0.276 | -0.464 | -0.595 | -0.52 | -0.562 | -0.398 | -0.485 | -0.793 | -0.514 | -0.686 | -0.525 | -0.445 | -0.47 | -0.801 | -1.892 | -1.362 | -0.931 | -0.985 | -0.948 |
| Income Tax Expense
| -0 | 0.882 | 0.043 | 1.73 | -0.722 | -0.45 | -0.016 | 0.905 | 0.225 | -0.157 | 0.053 | 0.63 | 0.164 | 0.223 | 0.41 | 0.868 | 0.87 | 0.872 | 0.893 | 0.856 | 0.893 | -14.36 | -5.852 | -2.169 | -0.887 | 1.204 |
| Net Income
| -16.603 | -14.136 | -13.011 | -12.788 | -13.484 | -16.01 | -12.598 | -10.319 | -15.398 | -16.679 | -14.693 | -13.885 | -10.539 | -10.694 | -16.756 | -10.315 | -10.353 | -9.941 | -8.291 | -8.007 | -11.959 | -24.158 | -15.619 | -8.952 | -7.651 | -5.408 |
| Net Income Ratio
| -0.324 | -0.292 | -0.275 | -0.288 | -0.298 | -0.399 | -0.314 | -0.276 | -0.464 | -0.595 | -0.52 | -0.562 | -0.398 | -0.485 | -0.793 | -0.514 | -0.686 | -0.525 | -0.445 | -0.47 | -0.801 | -1.892 | -1.362 | -0.931 | -0.985 | -0.948 |
| EPS
| -0.42 | -0.36 | -0.33 | -0.33 | -0.35 | -0.42 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 | -0.49 | -0.31 | -0.32 | -0.32 | -0.27 | -0.26 | -0.42 | -0.8 | -0.54 | -0.37 | -0.32 | -0.22 |
| EPS Diluted
| -0.42 | -0.36 | -0.33 | -0.33 | -0.35 | -0.42 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 | -0.49 | -0.31 | -0.32 | -0.32 | -0.27 | -0.26 | -0.42 | -0.8 | -0.54 | -0.37 | -0.32 | -0.22 |
| EBITDA
| -16.242 | -14.009 | -13.441 | -10.131 | -11.772 | -13.787 | -10.882 | -8.605 | -14.122 | -16.058 | -14.059 | -12.757 | -9.911 | -10.071 | -14.84 | -9.085 | -9.094 | -8.736 | -7.066 | -6.83 | -5.42 | -22.47 | -14.131 | -7.694 | -6.566 | -4.362 |
| EBITDA Ratio
| -0.317 | -0.289 | -0.284 | -0.228 | -0.26 | -0.344 | -0.272 | -0.23 | -0.426 | -0.573 | -0.497 | -0.516 | -0.375 | -0.457 | -0.702 | -0.453 | -0.602 | -0.461 | -0.379 | -0.401 | -0.363 | -1.76 | -1.232 | -0.8 | -0.845 | -0.764 |